Profibrotic Activation of Human Macrophages in Systemic Sclerosis. Issue 7 (31st May 2020)

• Record Type: Journal Article
• Authors: Bhandari, Rajan; Ball, Michael S.; Martyanov, Viktor; Popovich, Dillon; Schaafsma, Evelien; Han, Saemi; ElTanbouly, Mohamed; Orzechowski, Nicole M.; Carns, Mary; Arroyo, Esperanza; Aren, Kathleen; Hinchcliff, Monique; Whitfield, Michael L.; Pioli, Patricia A.
• Is Part Of: Arthritis & rheumatology. Volume 72:Issue 7(2020)
• Page Start: 1160
• Page End: 1169
• Publication Date: 2020-05-31
• Subjects: Arthritis -- Periodicals; Rheumatism -- Periodicals; 616.72
• DOI: 10.1002/art.41243
• Languages: English
• ISSNs: 2326-5191

Abstract

Abstract : Objective: Genome‐wide gene expression studies implicate macrophages as mediators of fibrosis in systemic sclerosis (SSc), but little is known about how these cells contribute to fibrotic activation in SSc. We undertook this study to characterize the activation profile of SSc monocyte‐derived macrophages and assessed their interaction with SSc fibroblasts. Methods: Plasma and peripheral blood mononuclear cells (PBMCs) were obtained from whole blood from SSc patients (n = 24) and age‐ and sex‐matched healthy controls (n = 12). Monocytes were cultured with autologous or allogeneic plasma to differentiate cells into macrophages. For reciprocal activation studies, macrophages were cocultured with fibroblasts using Transwell plates. Results: The gene expression signature associated with blood‐derived human SSc macrophages was enriched in SSc skin in an independent cohort and correlated with skin fibrosis. SSc macrophages expressed surface markers associated with activation and released CCL2, interleukin‐6, and transforming growth factor β under basal conditions (n = 8) ( P < 0.05). Differentiation of healthy donor monocytes in plasma from SSc patients conferred the immunophenotype of SSc macrophages (n = 13) ( P < 0.05). Transwell experiments demonstrated that coculture of SSc macrophages with SSc fibroblasts induced fibroblast activation (n = 3) ( P < 0.05). Conclusion: These data demonstrate that the activation profile of SSc macrophages is profibrotic. SSc macrophages are activated under basal conditions and release mediators and express surface markers associated with both alternative and inflammatory macrophage activation. These findings also suggest that activation of SSc macrophages arises from soluble factors in local microenvironments. These studies implicate macrophages as likely drivers of fibrosis in SSc and suggest that therapeutic targeting of these cells may be beneficial in ameliorating disease in SSc patients.